CJC-1295 / Ipamorelin™ is a dual-peptide research complex developed for advanced endocrine signaling studies. This combination pairs a growth hormone releasing hormone (GHRH) analog with a selective growth hormone secretagogue receptor (GHS-R) agonist, allowing researchers to examine coordinated pathway interaction within controlled laboratory models.

The structured pairing enables investigation into pituitary signaling dynamics, pulsatile hormone-release modeling, and downstream metabolic cascade analysis. By engaging complementary receptor mechanisms, this complex is frequently utilized in studies focused on adaptive endocrine regulation and multi-pathway signaling environments.